Document Detail

Multiple antimelanoma potential of dry olive leaf extract.
MedLine Citation:
PMID:  20568104     Owner:  NLM     Status:  In-Data-Review    
Various constituents of the olive tree (Olea europaea) have been traditionally used in the treatment of infection, inflammation, prevention of chronic diseases, cardiovascular disorders and cancer. The anticancer potential of dry olive leaf extract (DOLE) represents the net effect of multilevel interactions between different biologically active compounds from the extract, cancer cells and conventional therapy. In this context, it was of primary interest to evaluate the influence of DOLE on progression of the highly malignant, immuno- and chemoresistant type of skin cancer-melanoma. DOLE significantly inhibited proliferation and subsequently restricted clonogenicity of the B16 mouse melanoma cell line in vitro. Moreover, late phase tumor treatment with DOLE significantly reduced tumor volume in a syngeneic strain of mice. DOLE-treated B16 cells were blocked in the G(0) /G(1) phase of the cell cycle, underwent early apoptosis and died by late necrosis. At the molecular level, the dying process started as caspase dependent, but finalized as caspase independent. In concordance, overexpression of antiapoptotic members of the Bcl-2 family, Bcl-2 and Bcl-XL, and diminished expression of their natural antagonists, Bim and p53, were observed. Despite molecular suppression of the proapoptotic process, DOLE successfully promoted cell death mainly through disruption of cell membrane integrity and late caspase-independent fragmentation of genetic material. Taken together, the results of this study indicate that DOLE possesses strong antimelanoma potential. When DOLE was applied in combination with different chemotherapeutics, various outcomes, including synergy and antagonism, were observed. This requires caution in the use of the extract as a supplementary antitumor therapeutic.
Sanja A Mijatovic; Gordana S Timotijevic; Djordje M Miljkovic; Julijana M Radovic; Danijela D Maksimovic-Ivanic; Dragana P Dekanski; Stanislava D Stosic-Grujicic
Related Documents :
9216664 - Evidence of difference between cytotoxicity, cell cycle and morphonuclear effects of po...
10837354 - Role of multidrug resistance p-glycoprotein in the secretion of aldosterone by human ad...
8567404 - Non-p-glycoprotein-mediated atypical multidrug resistance in a human bladder cancer cel...
6169694 - Histochemical studies of mucosubstances in the epidermis of a nonscaly teleost mystus (...
6641814 - Melanin endocytosis by cultured mammalian cells. a model for melanin in a cellular envi...
20805224 - Seeded aggregation and toxicity of {alpha}-synuclein and tau: cellular models of neurod...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  International journal of cancer. Journal international du cancer     Volume:  128     ISSN:  1097-0215     ISO Abbreviation:  Int. J. Cancer     Publication Date:  2011 Apr 
Date Detail:
Created Date:  2011-02-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0042124     Medline TA:  Int J Cancer     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1955-65     Citation Subset:  IM    
Copyright Information:
Copyright © 2010 UICC.
Department of Immunology, Institute for Biological Research "Sinisa Stankovic," Belgrade University, Belgrade, Serbia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Trends in cervical cancer incidence and mortality in the Baltic countries, Bulgaria and Romania.
Next Document:  IL-2-granzyme A chimeric protein overcomes multidrug resistance (MDR) through a caspase 3-independen...